Alexander Gelbard

Alexander Gelbard

Vanderbilt University Medical Center

Director North American Airway Collaborative

More

Haven't backed any projects yet! 

In a Gresham Lecture in London, Surgeon Dr. Martin Elliott discusses the critical role of reliable and transparent data in surgical innovation.
Dr. Elliot discusses the importance of reliable and transparent outcomes surgical innovation
Kat, you are exactly right the small blue circle is TGF-B (beta). There are FDA approved drugs that block IL-17A (cosentyx and Talz). While there are not trials currently open to test this in iSGS - NoAAC is working on getting this going - so stay tuned.